20 Participants Needed

Fractionated 1927nm Laser for Hyperpigmentation

JB
AC
Overseen ByAbby Culver, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Texas Southwestern Medical Center
Stay on Your Current MedsYou can continue your current medications while participating
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The primary objective of this study is to assess the efficacy of 1927nm non-ablative fractionated laser therapy to treat hyperpigmentation in patients ages 18-75 with Fitzpatrick Skin Phototypes V and VI and explore an effective, adjunctive pre- and post-procedural regimen to prevent iatrogenic dyspigmentation or scarring in this population.

Who Is on the Research Team?

JK

Jeffrey Kenkel, MD

Principal Investigator

UT Southwestern- Department of Plastic Surgery

Are You a Good Fit for This Trial?

Adults aged 18-75 with darker skin tones (Fitzpatrick Skin Phototypes V and VI) who have noticeable hyperpigmentation on their face and are seeking treatment. Participants must be willing to avoid other aesthetic treatments, follow study procedures, use approved birth control if applicable, and not have any health conditions that could interfere with the trial.

Inclusion Criteria

Fitzpatrick Skin Phototype V and VI
Individuals who can read, speak, write, and understand English and who are willing to provide written informed consent
I am willing and able to follow all study instructions and treatments.
See 6 more

Exclusion Criteria

History of poor cooperation, unreliability, or noncompliance with medical treatment
I have a condition that could affect my skin's healing.
I am able to understand instructions and give informed consent.
See 21 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks
1 visit (in-person)

Treatment

Participants receive 1927nm non-ablative fractionated laser therapy for hyperpigmentation with treatments on Day 0, Day 30, and Day 60

2 months
3 visits (in-person)

Follow-up

Participants are monitored for changes in hyperpigmentation and adverse events at 1-month and 3-month follow-up visits

2 months
2 visits (in-person)

What Are the Treatments Tested in This Trial?

Interventions

  • MOXI
Trial Overview The trial is testing the effectiveness of a non-ablative fractionated laser therapy called MOXI for treating facial hyperpigmentation in individuals with darker skin types. It also aims to find a safe pre- and post-treatment skincare routine to prevent unwanted pigmentation or scarring.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Group I: Healthy Participants- Pre-Ttreatment OnlyExperimental Treatment1 Intervention
Group II: Healthy Participants- Post-Treatment OnlyExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Texas Southwestern Medical Center

Lead Sponsor

Trials
1,102
Recruited
1,077,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security